The impact of different doses of vitamin A supplementation on male and female mortality. A randomised trial from Guinea-Bissau
<p>Abstract</p> <p>Background</p> <p>Vitamin A supplementation (VAS) given to children between 6 months and 5 years of age is known to reduce mortality in low-income countries. We have previously observed that girls benefit more from a lower dose of VAS than the one rec...
Na minha lista:
Principais autores: | , , , , , , |
---|---|
Formato: | Livro |
Publicado em: |
BMC,
2011-09-01T00:00:00Z.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_dc2bccbecc9c42c297ea4a814bd5190f | ||
042 | |a dc | ||
100 | 1 | 0 | |a Diness Birgitte R |e author |
700 | 1 | 0 | |a Martins Cesario |e author |
700 | 1 | 0 | |a Benn Christine S |e author |
700 | 1 | 0 | |a Yakymenko Dorthe |e author |
700 | 1 | 0 | |a Fisker Ane B |e author |
700 | 1 | 0 | |a Rodrigues Amabelia |e author |
700 | 1 | 0 | |a Aaby Peter |e author |
245 | 0 | 0 | |a The impact of different doses of vitamin A supplementation on male and female mortality. A randomised trial from Guinea-Bissau |
260 | |b BMC, |c 2011-09-01T00:00:00Z. | ||
500 | |a 10.1186/1471-2431-11-77 | ||
500 | |a 1471-2431 | ||
520 | |a <p>Abstract</p> <p>Background</p> <p>Vitamin A supplementation (VAS) given to children between 6 months and 5 years of age is known to reduce mortality in low-income countries. We have previously observed that girls benefit more from a lower dose of VAS than the one recommended by WHO, the effect being strongest if diphtheria-tetanus-pertussis vaccine (DTP) was the most recent vaccination. We aimed to test these observations.</p> <p>Methods</p> <p>During national immunisations days in Guinea-Bissau, West Africa, combining oral polio vaccination and VAS, we randomised 8626 children between 6 months and 5 years of age to receive the dose of VAS recommended by WHO or half this dose. Mortality rate ratios (MRRs) were assessed after 6 and 12 month.</p> <p>Results</p> <p>The overall mortality rate among participants was lower than expected. There was no significant difference in mortality at 6 months and 12 months of follow up between the low dose VAS group and the recommended dose VAS group. The MRRs were 1.23 (0.60-2.54) after 6 months and 1.17 (0.73-1.87) after 12 months. This tendency was similar in boys and girls. The low dose was not associated with lower mortality in girls if the most recent vaccine was DTP (MRR = 0.60 (0.14-2.50) after 6 months).</p> <p>Conclusion</p> <p>Our sample size does not permit firm conclusions since mortality was lower than expected. We could not confirm a beneficial effect of a lower dose of VAS on mortality in girls.</p> <p>Trial registration</p> <p>The study was registered under clinicaltrials.gov, number <a href="http://www.clinicaltrials.gov/ct2/show/NCT00168636">NCT00168636</a></p> | ||
546 | |a EN | ||
690 | |a Pediatrics | ||
690 | |a RJ1-570 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n BMC Pediatrics, Vol 11, Iss 1, p 77 (2011) | |
787 | 0 | |n http://www.biomedcentral.com/1471-2431/11/77 | |
787 | 0 | |n https://doaj.org/toc/1471-2431 | |
856 | 4 | 1 | |u https://doaj.org/article/dc2bccbecc9c42c297ea4a814bd5190f |z Connect to this object online. |